- Home
- BLRX vs IGTA Comparison
BLRX vs IGTA Comparison
Compare BLRX & IGTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLRX
- IGTA
- Stock Information
- Founded
- BLRX 2003
- IGTA 2021
- Country
- BLRX Israel
- IGTA United States
- Employees
- BLRX N/A
- IGTA N/A
- Industry
- BLRX Biotechnology: Pharmaceutical Preparations
- IGTA Blank Checks
- Sector
- BLRX Health Care
- IGTA Finance
- Exchange
- BLRX Nasdaq
- IGTA Nasdaq
- Market Cap
- BLRX 36.0M
- IGTA 46.2M
- IPO Year
- BLRX 2011
- IGTA 2021
- Fundamental
- Price
- BLRX $0.20
- IGTA $11.08
- Analyst Decision
- BLRX Strong Buy
- IGTA
- Analyst Count
- BLRX 2
- IGTA 0
- Target Price
- BLRX $5.50
- IGTA N/A
- AVG Volume (30 Days)
- BLRX 1.7M
- IGTA 13.9K
- Earning Date
- BLRX 11-25-2024
- IGTA 01-01-0001
- Dividend Yield
- BLRX N/A
- IGTA N/A
- EPS Growth
- BLRX N/A
- IGTA 29.68
- EPS
- BLRX N/A
- IGTA 0.12
- Revenue
- BLRX $21,991,000.00
- IGTA N/A
- Revenue This Year
- BLRX N/A
- IGTA N/A
- Revenue Next Year
- BLRX N/A
- IGTA N/A
- P/E Ratio
- BLRX N/A
- IGTA $99.46
- Revenue Growth
- BLRX N/A
- IGTA N/A
- 52 Week Low
- BLRX $0.19
- IGTA $10.64
- 52 Week High
- BLRX $1.68
- IGTA $12.49
- Technical
- Relative Strength Index (RSI)
- BLRX 25.94
- IGTA 39.90
- Support Level
- BLRX $0.23
- IGTA $10.52
- Resistance Level
- BLRX $0.56
- IGTA $12.00
- Average True Range (ATR)
- BLRX 0.03
- IGTA 0.24
- MACD
- BLRX 0.00
- IGTA -0.06
- Stochastic Oscillator
- BLRX 11.82
- IGTA 28.43
About BLRX BioLineRx Ltd.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
About IGTA Inception Growth Acquisition Limited
Inception Growth Acquisition Ltd is a blank check company.